Studying Inflammation and Metabolism After Cardiac Arrest in Adults
Observes blood changes in adults for 7 days after cardiac arrest, and recovery.
Key facts
- Who runs it
- MaineHealth
- Where
- Portland, United StatesSee the site
- Trial code
- Registry title
- Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- Jan 2016
- Expected to end
- Jan 2028
- Type of study
- Observational
- Record updated
- 18 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in intensive care who are unresponsive after a cardiac arrest and resuscitation. Blood samples are taken over 7 days.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Admitted to the intensive care unit after a cardiac arrest and still unresponsive after resuscitation.
Main reasons for not taking part
- Moribund or actively dying at the time of evaluation
- Informed consent cannot be obtained within 24 hours of resuscitation
- Hemoglobin less than 7.0 g/dL
- Active high-volume bleeding
- Requiring a transfusion
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Aged 18 years or older
- Admitted to the intensive care unit after cardiac arrest episode
- Unresponsive after resuscitation
Who cannot take part
- Hemoglobin less than 7.0 g/dL, active high-volume bleeding, or requiring a transfusion
- Moribund / actively dying at the time of evaluation
- Informed consent cannot be obtained within 24 hours of resuscitation
Where in United States
- Maine Medical CenterPortland, United StatesContact: David B Seder, MDTaking people
About the trial
What the trial wants to find out
This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces changes in the numbers and properties of circulating immune cells, shifting the balance towards a pro-inflammatory phenotype and there is increased interest in the inflammatory pathways and the signaling mechanisms through which they are modulated. Participants will undergo blood sampling during 7 days following cardiac arrest, and analyses performed. Patient characteristics, clinical circumstances, and outcomes will be recorded and their associations with these inflammatory pathways characterized.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Immunoinflammatory and Metabolic Responses in Post Cardiac Arrest Syndrome (PCAS)
- Plain-language title
- Studying Inflammation and Metabolism After Cardiac Arrest in AdultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 18 July 2025